Evaxion A EVAX
NASDAQ EVAX
$3.35 +0.08 (+2.45%)
As of: Sep 30, 2026 · 9:30 AM EDT

Evaxion A (EVAX) EBIT Margin (2024 - 2025)

Updated

Evaxion A's EBIT Margin was -122.66% in FY2025, up 317.89 percentage points from -440.55% in FY2024.

Analysis

Evaxion A (EVAX) EBIT Margin (2024 - 2025) Analysis & Trends

  • Per Business Quant data, EBIT Margin in earlier years was -440.55% in FY2024 (+29966.30 pp) and -30406.85% in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 28.21%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 37.86%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -3.52%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 32.97%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 20.57%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 34.95%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -133.21%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 28.37%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 37.40%
10 Evaxion A 20.76 Mn -45.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 40.34%
Jun 30, 2025 -11,729.73%
Dec 31, 2024 -3,298.36%
Sep 30, 2024 -57.37%
Jun 30, 2024 -2,974.68%
Mar 31, 2024 -8,619.61%
API Access

Evaxion A EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=EVAX&period=max&api_key=YOUR_API_KEY